ARCHIVES

Trial Data: No Benefit In Adding Perifosine to Capecitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

In Brief: Obey Fears Hangup On Abortion Funding will Kill Labor-Hew Appropriations Bill

July 6, 1979

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

January 6, 1989

Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach.

July 9, 2004

Rauscher For Cancer Program

May 20, 1977

Holland On The Next 10 Years; Progress In Prevention, Diagnosis, Therapy

March 23, 1984